Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Dold

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Journal of Affective Disorders|March 23, 2023
Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorderLucie Bartova, Gernot Fugger, Markus Dold, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 9, 2025
Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater-blinded phase IIIb studyEduard Vieta, Nahida Ahmed, Celso Arango, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 24, 2018
Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samplesChiara Fabbri, Siegfried Kasper, Alexander Kautzky, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 28, 2024
The clinical perspective on late-onset depression in European real-world treatment settingsLucie Bartova, Gernot Fugger, Markus Dold, et al.
Journal of Affective Disorders|March 16, 2021
The Role of Relationship Status in Major Depressive Disorder - Results of the European Group for the Study of Resistant DepressionLucie Bartova, Markus Dold, Gernot Fugger, et al.
Depression and Anxiety|June 10, 2021
Sex-related effects in major depressive disorder: Results of the European Group for the Study of Resistant DepressionLucie Bartova, Markus Dold, Gernot Fugger, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Journal of Affective Disorders|March 23, 2023
Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorderLucie Bartova, Gernot Fugger, Markus Dold, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 9, 2025
Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater-blinded phase IIIb studyEduard Vieta, Nahida Ahmed, Celso Arango, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 24, 2018
Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samplesChiara Fabbri, Siegfried Kasper, Alexander Kautzky, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 28, 2024
The clinical perspective on late-onset depression in European real-world treatment settingsLucie Bartova, Gernot Fugger, Markus Dold, et al.
Journal of Affective Disorders|March 16, 2021
The Role of Relationship Status in Major Depressive Disorder - Results of the European Group for the Study of Resistant DepressionLucie Bartova, Markus Dold, Gernot Fugger, et al.
Depression and Anxiety|June 10, 2021
Sex-related effects in major depressive disorder: Results of the European Group for the Study of Resistant DepressionLucie Bartova, Markus Dold, Gernot Fugger, et al.
Pageof 7